Home/Axelia Oncology/Ardian Latifi, PhD
AL

Ardian Latifi, PhD

Director, Clinical Operations

Axelia Oncology

Therapeutic Areas

Axelia Oncology Pipeline

DrugIndicationPhase
AXA-042Solid Tumors (checkpoint‑insensitive)Phase 1